News

Biochemists at The Scripps Research Institute (TSRI) have discovered a genetic sequence that can alter its host gene’s activity in response to cellular energy levels.

A class of membrane-sculpting proteins create vesicles that carry old and damaged proteins from the surface of cellular compartments into internal recycling plants where the waste is degraded and components are reused.

Across the United States, fields of genetically engineered crops have become laboratories for the evolution of glyphosate-resistant (GR) weeds.

A new non-executive director joins Cobra’s board to support expansion plans.

CellAura is a UK-based company with a unique drug discovery technology which allows molecular interactions to be visualised in real time at a cellular level.

Collaboration agreement in the field of GPCR-based drug discovery.

Researchers from Ludwig-Maximilians-Universität München have determined the solid-state structure of the Dess–Martin periodinane, a popular reagent in organic synthesis.

New company to focus on oral drugs for hepatitis C and hereditary angioedema. Combined HCV portfolio includes three complementary viral targeting mechanisms.

In this article a variety of experts from within Medicinal Chemistry discuss key issues concerning the use of flow chemistry to optimize drug development.

The Committee for Medicinal Products for Human Use adopted positive opinions, recommending marketing authorisations, for Tresiba® and Ryzodeg® for the treatment of diabetes mellitus in adults.